Tchaikapharma High Quality Medicines AD Past Earnings Performance
Past criteria checks 1/6
Tchaikapharma High Quality Medicines AD's earnings have been declining at an average annual rate of -16.2%, while the Pharmaceuticals industry saw earnings growing at 7.5% annually. Revenues have been growing at an average rate of 5.9% per year. Tchaikapharma High Quality Medicines AD's return on equity is 1.8%, and it has net margins of 3.9%.
Key information
-16.2%
Earnings growth rate
-17.8%
EPS growth rate
| Pharmaceuticals Industry Growth | 12.4% |
| Revenue growth rate | 5.9% |
| Return on equity | 1.8% |
| Net Margin | 3.9% |
| Last Earnings Update | 30 Jun 2024 |
Revenue & Expenses Breakdown
How Tchaikapharma High Quality Medicines AD makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 50 | 2 | 25 | 0 |
| 31 Mar 24 | 48 | 3 | 33 | 0 |
| 31 Dec 23 | 49 | 3 | 28 | 0 |
| 30 Sep 23 | 50 | 4 | 34 | 0 |
| 30 Jun 23 | 46 | 4 | 28 | 0 |
| 31 Mar 23 | 44 | 3 | 24 | 0 |
| 31 Dec 22 | 43 | 3 | 24 | 0 |
| 30 Sep 22 | 40 | 1 | 6 | 0 |
| 30 Jun 22 | 43 | 1 | 6 | 0 |
| 31 Mar 22 | 42 | 0 | 6 | 0 |
| 31 Dec 21 | 42 | 1 | 6 | 0 |
| 30 Sep 21 | 42 | 0 | 6 | 0 |
| 30 Jun 21 | 41 | 0 | 5 | 0 |
| 31 Mar 21 | 43 | 1 | 5 | 0 |
| 31 Dec 20 | 40 | 0 | 5 | 0 |
| 30 Sep 20 | 39 | 2 | 5 | 0 |
| 30 Jun 20 | 38 | 1 | 4 | 0 |
| 31 Mar 20 | 36 | 1 | 4 | 0 |
| 31 Dec 19 | 35 | 3 | 4 | 0 |
| 30 Sep 19 | 39 | 9 | 4 | 0 |
| 30 Jun 19 | 38 | 11 | 4 | 0 |
| 31 Mar 19 | 38 | 11 | 4 | 0 |
| 31 Dec 18 | 38 | 11 | 4 | 0 |
| 30 Sep 18 | 35 | 10 | 4 | 0 |
| 30 Jun 18 | 35 | 10 | 4 | 0 |
| 31 Mar 18 | 35 | 9 | 4 | 0 |
| 31 Dec 17 | 33 | 9 | 4 | 0 |
| 30 Sep 17 | 34 | 7 | 4 | 0 |
| 30 Jun 17 | 33 | 8 | 4 | 0 |
| 31 Mar 17 | 32 | 9 | 3 | 0 |
| 31 Dec 16 | 33 | 9 | 3 | 0 |
| 30 Sep 16 | 32 | 9 | 3 | 0 |
| 30 Jun 16 | 32 | 8 | 3 | 0 |
| 31 Mar 16 | 31 | 8 | 3 | 0 |
| 31 Dec 15 | 30 | 8 | 4 | 0 |
| 30 Sep 15 | 33 | 7 | 4 | 0 |
| 30 Jun 15 | 32 | 7 | 5 | 0 |
| 31 Mar 15 | 30 | 7 | 5 | 0 |
| 31 Dec 14 | 29 | 7 | 5 | 0 |
| 31 Dec 13 | 26 | 6 | 3 | 0 |
Quality Earnings: THQM has high quality earnings.
Growing Profit Margin: THQM's current net profit margins (3.9%) are lower than last year (9.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: THQM's earnings have declined by 16.2% per year over the past 5 years.
Accelerating Growth: THQM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: THQM had negative earnings growth (-57.1%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (2.5%).
Return on Equity
High ROE: THQM's Return on Equity (1.8%) is considered low.